Table 1.
Baseline patient characteristics of patients with COVID-19 with QT prolongation
| Characteristic | Value |
|---|---|
| Age (y) | 68.2 ± 15.2 |
| QT interval (ms) | 448.0 ± 44.7 |
| QTc interval (ms) | 507.5 ± 28.5 |
| BMI (kg/m2) | 28.9 ± 7.1 |
| Male sex | 64 (62.1) |
| Severity of disease | |
| ICU during hospitalization | 60 (58.3) |
| Intubation during hospitalization | 32 (31.1) |
| Medical comorbidities | |
| HTN | 61 (59.2) |
| Diabetes mellitus | 50 (48.5) |
| HLD | 33 (32.0) |
| CKD/ESRD | 32 (31.1) |
| AF/AFL | 20 (19.4) |
| CAD | 19 (18.4) |
| Lung disease | 18 (17.5) |
| Morbid obesity | 17 (16.5) |
| Heart failure | 16 (15.5) |
| CVA/TIA | 14 (13.6) |
| Obstructive sleep apnea | 14 (13.6) |
| Malignancy | 14 (13.6) |
| Cognitive impairment/dementia | 12 (11.7) |
| Cardiovascular implantable electrical devices | 11 (10.7) |
| Liver disease | 9 (8.7) |
| Alcohol abuse/substance abuse | 4 (3.9) |
| HIV/AIDS | 3 (2.9) |
Values are presented as mean ± SD or as n (%).
Malignancy was defined as active cancer or a history of cancer that was treated with chemotherapy.
AF = atrial fibrillation; AFL = atrial flutter; BMI = body mass index; CAD = coronary artery disease; CKD = chronic kidney disease; COVID-19 = coronavirus disease 2019; CVA = cerebrovascular accident; ESRD = end-stage renal disease; HLD = hyperlipidemia; HTN = hypertension; ICU = intensive care unit; QTc = corrected QT; TIA = transient ischemic accident.